Trials / Terminated
TerminatedNCT02963363
Adapted Physical Activity for Breast Cancer HER2 Positive Patient
Feasibility Study of an Adapted Physical Activity (APA) for Breast Cancer Patients Treated by Neoadjuvant Chemotherapy and Targeted Therapy Against HER2
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Centre Jean Perrin · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the feasibility of a home-based adapted physical activity during neoadjuvant chemotherapy for HER2+ breast cancer.
Detailed description
After the assessment of their physical fitness, a home-based adapted physical activity program composed by aerobic and muscle strengthening exercises will be delivered to each patient. The aim of the intervention is to reach international recommendation in a progressive way during neoadjuvant chemotherapy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Home-based Adapted Physical Activity | Home-based adapted physical activity to attend progressively 150 minutes of physical activity per week at the end of neoadjuvant chemotherapy. 5 times 30 minutes of walking + 3 times 30 minutes of muscle strengthening exercises per week during 18 weeks |
Timeline
- Start date
- 2018-04-27
- Primary completion
- 2022-08-19
- Completion
- 2023-08-11
- First posted
- 2016-11-15
- Last updated
- 2023-11-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02963363. Inclusion in this directory is not an endorsement.